30 likes | 214 Views
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial. Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial. Borer JS, et al. Am J Cardiol . 2013. 2014;113(3):497-503.
E N D
Systolic Heart failure treatment withthe Ifinhibitor ivabradineTrial Efficacy and safety of ivabradine in patients with severe chronic systolic heart failure/left ventricular dysfunction in the SHIFT trial Borer JS, et al. Am J Cardiol. 2013. 2014;113(3):497-503 www.shift-study.com
Efficacy of ivabradine in patients according to heart failure severity Ivabradine can be safely used in severe heart failure, and may improve clinical outcomes, independently of disease severity Borer JS, et al. Am J Cardiol. 2013. 2014;113(3):497-503 www.shift-study.com
Efficacy of ivabradine in patients according to heart failure severity Borer JS, et al. Am J Cardiol. 2013. 2014;113(3):497-503 www.shift-study.com